Search Results

The Optilite Rheumatoid Factor (RF) Kit is intended for the quantitative in vitro measurement of rheumatoid factor in serum using the Binding Site Optilite analyser. Measurement of rheumatoid factor may aid in the diagnosis of rheumatoid arthritis. This test should be used in conjunction with other laboratory and clinical findings.

Device Description

The Optilite Rheumatoid Factor Kit comprises the following reagents: Reaction Buffer, Latex Reagent, RF Controls (supplied at 2 levels, Low and High), and RF Calibrator.

AI/ML Overview

Here's an analysis of the provided text, focusing on the acceptance criteria and the study that proves the device meets them, structured according to your requested information:

1. Table of Acceptance Criteria and the Reported Device Performance

Performance Characteristic	Acceptance Criteria	Reported Device Performance
Precision/Reproducibility
Total Precision	%CV < 10%	All levels: 3.8% - 6.9%
Within-run Precision	%CV < 5%	All levels: 0.6% - 2.5%
Between-run Precision	%CV < 8%	All levels: 1.3% - 2.2%
Between-day Precision	%CV < 8%	All levels: 3.2% - 6.0%
Linearity/Assay Range	%CV for each sample ≤ 8%; Allowable nonlinearity ±10% or 10% of the medical decision point.	Observed nonlinearity was less than 10%, or 10% of the medical decision point.
Analytical Specificity	For non-interference, mean results from spiked samples must be within 10% of the mean of control samples.	Data demonstrated the assay was not affected by listed interferents at specified concentrations.
Method Comparison	N/A (Comparative study, not a performance criterion directly stated as "acceptance")	Passing Bablok slope 0.90 (95% CI: 0.87 to 0.97), Intercept 2.51 IU/mL (95% CI: 0.76 to 3.88), Pearson's r 0.984

2. Sample Size Used for the Test Set and the Data Provenance

Precision/Reproducibility: 5 sample preparations, each tested 84 times (2 runs/day, 2 duplicates/run, over 21 days).
Linearity/Assay Range: A dilution series comprising a high pool and a low pool, tested in 3 replicates.
Method Comparison with Predicate Device: 103 samples tested.
Analytical Sensitivity (LoD/LoB/LoQ):
- LoB: 60 determinations of a blank sample.
- LoD: 6 determinations of 4 samples near the lower limit of the reportable range.
Analytical Specificity: Not explicitly stated, but samples were spiked with interfering substances.

Data Provenance: The document does not explicitly state the country of origin of the samples or whether they were retrospective or prospective. Given the manufacturer is based in the UK and it's a medical device submission, it's plausible the data collection occurred within a regulatory-compliant framework, potentially from a clinical laboratory setting.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

There is no mention of experts being used to establish ground truth in the context of the analytical performance studies (precision, linearity, specificity, method comparison). This device is an in vitro diagnostic (IVD) for quantitative measurement of Rheumatoid Factor, and its performance is assessed through analytical validation against an established reference standard (WHO 64/2) and comparison with a predicate device. Ground truth, in this context, refers to the known concentration or behavior of the analyte, verified through laboratory methods rather than expert clinical consensus.

4. Adjudication Method for the Test Set

Not applicable. The studies described are analytical performance validations, which do not involve subjective interpretation or adjudication by experts. The results are quantitative measurements against defined criteria and methods.

5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a fully automated in vitro diagnostic (IVD) kit for measuring a biomarker; it does not involve human "readers" or Artificial Intelligence (AI) in its measurement process. Therefore, an MRMC comparative effectiveness study comparing human readers with and without AI assistance is irrelevant to this device.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

Yes, the studies detailed in "1. Analytical performance" and "2. Comparison studies" demonstrate the standalone performance of the Optilite® Rheumatoid Factor Kit without human intervention in the measurement process after the sample is introduced to the analyzer. The device performs the quantitative analysis automatically.

7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)

The primary ground truth for the quantitative measurement performed by this device is:

International Reference Preparation: The calibration of the assay is traceable to the International Reference Preparation of Rheumatoid Arthritis Serum WHO 64/2. This standard serves as the "ground truth" for the quantitative accuracy of Rheumatoid Factor levels.
Predicate Device/Established Methods: For method comparison, an alternative commercially available assay (presumably a legally marketed and validated method) served as a comparative ground truth.

For analytical performance studies (precision, linearity, specificity), the ground truth is either:

Known concentrations: Samples with known or spiked concentrations of analytes or interferents.
Blank samples: Samples known to contain no analyte (for Limit of Blank).

8. The Sample Size for the Training Set

Not applicable. This device is an immunoassay kit, not an AI/machine learning algorithm. Therefore, there is no "training set" in the context of developing the device. The reagents and assay parameters are developed based on biochemical principles and optimized through laboratory testing, not machine learning.

9. How the Ground Truth for the Training Set was Established

Not applicable, as there is no "training set" for this type of device.

Ask a Question

Ask a specific question about this device

Page 1 of 1